Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764156016 | Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3764157013 | Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has presentation strength numerator value | 4 | false | Inferred relationship | Some | 1 | |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has precise active ingredient | Ondansetron hydrochloride | true | Inferred relationship | Some | 1 | |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has BoSS | Ondansetron | true | Inferred relationship | Some | 1 | |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | Ondansetron only product in oromucosal dose form | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Plays role | Antiemetic therapeutic role | true | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | Ondansetron only product in oral dose form | true | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | Ondansetron-containing product | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has active ingredient | Ondansetron | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | Ondansetron-containing product in oral dose form | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Has manufactured dose form | Orodispersible tablet | true | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | Ondansetron-containing product in oromucosal dose form | false | Inferred relationship | Some | ||
| Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR